psychiatryRounds

Connecting Psychiatry - Expert community for all mental health professionals

(PSYCHIATRIC TIMES) - BOSTON, Jan. 8 -- Clinical and research developments in neurology in 2006 seemed to be as much about prevention as treatment.

Among the highlights were the return to the market of Tysabri (natalizumab) for multiple sclerosis, a treatment for Parkinson's dementia, the ongoing struggles to understand the causes and treatment of autism spectrum disorders, and new evidence about the influence of diet in preventing cognitive decline.

For full article, please visit:
http://www.psychiatrictimes.com/neurology/article/10162/17924

Views: 6

Comment

You need to be a member of psychiatryRounds to add comments!

Join psychiatryRounds


psychiatryRounds Social Media

Sponsors

CMEinfo: Board Reviews in Anesthesia, Cardiology, Internal Medicine, Radiology

© 2019   Created by PsychiatryRounds Team.   Powered by

Badges  |  Report an Issue  |  Terms of Service